Tag: Stem Cell Therapy For Infertility Market Growth

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Stem Cell Therapy For Infertility Market Size, Value And Growth Trends Through 2030

The market for stem cell therapy in addressing infertility has experienced significant expansion lately. Projections indicate a rise from $1.87 billion in 2025 to $2.18 billion in 2026, reflecting a compound annual growth rate of 16.6%. Factors contributing to this growth historically include a higher incidence of infertility challenges, an increase in fertility clinics worldwide, breakthroughs in reproductive biology research, a growing preference for alternative infertility solutions, and the widespread adoption of assisted reproductive techniques.

Anticipate a swift expansion in the stem cell therapy for infertility market during the forthcoming years, projecting a valuation of $3.99 billion by 2030, fueled by a compound annual growth rate (CAGR) of 16.4%. This projected increase is bolstered by several key factors, including the escalating clinical confirmation of stem cell applications in treating infertility, a surge in financial backing for regenerative medicine in reproduction, a greater embrace of individualized fertility approaches, the broadening scope of clinical trials within reproductive health, and strengthened partnerships between fertility centers and academic research bodies. Prominent developments anticipated within this timeframe encompass a heightened emphasis on therapies aimed at ovarian and testicular regeneration, an increased deployment of treatments utilizing a patient’s own stem cells, deeper integration with assisted reproductive technologies, the broadening of tailored fertility treatment methodologies, and significant advancements in clinical investigations concerning reproductive regeneration.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30408&type=smp

Stem Cell Therapy For Infertility Market Growth Drivers: What Factors Are Accelerating Expansion?

Continued proliferation of infertility incidents is anticipated to be a major catalyst for the advancement of the stem cell therapy market focused on reproductive health. Infertility, defined as the failure of a couple to achieve pregnancy following at least a year of consistent, unprotected sexual activity, is increasingly prevalent. A primary driver behind this trend is the postponement of parenthood, with individuals opting for children at later stages of life. This delay leads to diminished fertility as the natural reproductive capacity wanes with age, a phenomenon particularly pronounced in women. Stem cell therapies present viable prospects for addressing infertility by facilitating the repair of compromised reproductive tissues, boosting the functionality of both ovaries and testes, and thereby increasing the likelihood of successful conception. Illustrating the scale of this issue, data from April 2023, as reported by the World Health Organization (WHO), a global intergovernmental body headquartered in Switzerland, indicates that infertility impacts roughly 17.5% of adults worldwide, translating to approximately one in six individuals, underscoring the escalating demand for accessible and effective fertility treatments. Consequently, the surge in infertility cases is poised to propel the growth of the stem cell therapy market dedicated to reproductive well-being.

Stem Cell Therapy For Infertility Market Segment Outlook: Which Categories Are Expanding The Fastest?

The stem cell therapy for infertility market covered in this report is segmented –

1) By Type: Male Infertility Treatment, Female Infertility Treatment

2) By Treatment Type: Autologous Stem Cell Therapy, Allogeneic Stem Cell Therapy, Combination Therapy

3) By Cell Source: Embryonic Stem Cells, Adult Stem Cells, Induced Pluripotent Stem Cells

4) By Application: Ovarian Insufficiency, Uterine Infertility, Genetic Disorders

5) By End User: Hospitals, Specialty Clinics, Research Institutes

Subsegments:

1) By Male Infertility Treatment: Surgical Sperm Retrieval, Hormonal Therapy, Stem Cell Transplantation, Assisted Reproductive Techniques

2) By Female Infertility Treatment: Ovarian Stem Cell Therapy, Endometrial Regeneration Therapy, Hormonal Therapy, In Vitro Fertilization Enhancement

Stem Cell Therapy For Infertility Market Trends: What Is Shaping Future Industry Growth?

In the realm of stem cell therapies for infertility, leading enterprises are dedicating their efforts to pioneering innovations in stem cell technology, particularly with induced pluripotent stem cells (iPSCs). This strategic focus aims to refine regenerative treatments tailored to individuals, bolster outcomes specific to each patient, and broaden the scope of reproductive ailments that can be addressed. Induced pluripotent stem cells function by reverting mature, specialized body cells to an undifferentiated, embryonic-like state, granting them the potential to develop into nearly any cell within the human organism. A notable development occurred in January 2025 when Gameto Inc., a biotechnology firm situated in the United States, commenced a crucial Phase III clinical investigation for Fertilo, its iPSC-based fertility treatment. This trial received approval through an Investigational New Drug (IND) application granted by the U.S. Food and Drug Administration (FDA). The study, which will involve around 15 locations throughout the U.S., is designed to assess the maturation of eggs outside the body, supported by specially developed ovarian support cells. This novel approach holds the promise of not only abbreviating the duration of in-vitro fertilization (IVF) cycles but also potentially diminishing the need for hormonal stimulation by as much as 80%. The successful conclusion of this trial would mark a significant milestone, establishing it as the inaugural late-stage clinical program for a therapy involving in-vitro egg maturation derived from induced pluripotent stem cells in the management of infertility.

Stem Cell Therapy For Infertility Market Key Companies And Competitive Benchmarking

Major companies operating in the stem cell therapy for infertility market are PlacidWay LLC, New Life India Fertility Clinic Private Limited, Jeevan Mithra Fertility Centre Private Limited, Equipo IVI S.L., Hope Fertility & Stem Cell Centre Pvt. Ltd., Bioscience Institute SpA, Advancells Dermaceuticals Private Limited, GIOSTAR INDIA PRIVATE LIMITED, Shree IVF Clinic Private Limited, Stem Cells Care (india) Private Limited, GenCell Ltd., StemRx BioScience Solutions Private Limited., Kiran Infertility Centre Private Limited, R3 Stem Cell LLC., Bavishi Fertility Institute Private Limited, Seragen Biotherapeutics Private Limited, Esha IVF Fertility Centre Private Limited, Embryonic Tissue Center EmCell, InoCells B.V., Vega Stem Cell Clinic Co. Ltd.

Access The Complete Stem Cell Therapy For Infertility Market Report:

https://www.thebusinessresearchcompany.com/report/global-stem-cell-therapy-for-infertility-market-report

Stem Cell Therapy For Infertility Market Largest Region: Which Geography Holds The Highest Market Share?

North Americawas the largest region in the stem cell therapy for infertility market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the stem cell therapy for infertility market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Estimated Growth In Market Size Of The Stem Cell Therapy For Infertility Market During 2026–2030?

The stem cell therapy for infertility market size has experienced significant expansion in recent years. It is anticipated to grow from $1.87 billion in 2025 to $2.18 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 16.6%. The historical surge in this market can be ascribed to a combination of factors, including the increasing prevalence of infertility conditions, the worldwide proliferation of fertility clinics, continuous advancements in reproductive biology research, a rising demand for alternative infertility treatments, and the broader expansion of assisted reproductive procedures.

The stem cell therapy for infertility market is poised for substantial expansion in the coming years, with projections indicating a rise to $3.99 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 16.4%. This anticipated growth is driven by several factors, including the increasing clinical validation of stem cell infertility treatments, a surge in investments directed towards reproductive regenerative medicine, the growing embrace of personalized fertility solutions, an expansion of clinical trials within reproductive health, and enhanced collaboration between fertility clinics and research institutions. Prominent trends throughout the forecast period encompass a heightened focus on ovarian and testicular regeneration therapies, an increasing adoption of autologous stem cell treatments, greater integration with assisted reproductive technologies, the broadening of personalized fertility treatment protocols, and advanced clinical research in reproductive regeneration.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30408&type=smp

What Market Drivers Are Helping Shape The Stem Cell Therapy For Infertility Market Expansion?

The increasing incidence of infertility is projected to be a major contributor to the future expansion of the stem cell therapy for infertility market. Infertility is defined as a couple’s inability to achieve conception after 12 months or longer of consistent unprotected sexual activity. A primary reason for the growing occurrence of infertility is delayed childbearing, where many individuals opt to start families later, leading to a natural decrease in reproductive potential with advancing age, especially in women. Promising solutions are offered by stem cell therapy for infertility through the regeneration of damaged reproductive tissues, enhancement of ovarian and testicular function, and an improved likelihood of conception. For example, a report released in April 2023 by the World Health Organization (WHO), an intergovernmental organization based in Switzerland, indicated that around 17.5% of the adult population, or approximately 1 in 6 individuals worldwide, are impacted by infertility. This underscores the increasing necessity for broader access to affordable and high-quality fertility treatments. Consequently, the escalating rates of infertility are anticipated to fuel the growth of the stem cell therapy for infertility market.

How Does Segment Analysis Break Down The Stem Cell Therapy For Infertility Market Structure?

The stem cell therapy for infertility market covered in this report is segmented –

1) By Type: Male Infertility Treatment, Female Infertility Treatment

2) By Treatment Type: Autologous Stem Cell Therapy, Allogeneic Stem Cell Therapy, Combination Therapy

3) By Cell Source: Embryonic Stem Cells, Adult Stem Cells, Induced Pluripotent Stem Cells

4) By Application: Ovarian Insufficiency, Uterine Infertility, Genetic Disorders

5) By End User: Hospitals, Specialty Clinics, Research Institutes

Subsegments:

1) By Male Infertility Treatment: Surgical Sperm Retrieval, Hormonal Therapy, Stem Cell Transplantation, Assisted Reproductive Techniques

2) By Female Infertility Treatment: Ovarian Stem Cell Therapy, Endometrial Regeneration Therapy, Hormonal Therapy, In Vitro Fertilization Enhancement

Which Trends Are Shaping The Stem Cell Therapy For Infertility Market Landscape?

Leading companies operating within the stem cell services market are prioritizing advancements such as single-use consumable systems, aiming to enhance process efficiency, mitigate contamination risks, and optimize end-to-end cell therapy manufacturing. A single-use consumable system defines a production method where equipment that comes into contact with biological substances is designed for one-time use, thereby considerably reducing contamination potential and improving overall output efficiency. For instance, in March 2025, Limula SA, a Switzerland-based life science tools company, introduced LimONE, an innovative platform for comprehensive cell therapy manufacturing engineered to automate and integrate complex, fragmented processes into a single, seamless workflow. This system consolidates various unit operations into one enclosed consumable, consequently reducing labor, equipment, and infrastructure needs, all while ensuring process standardization, scalability, and faster production timelines for highly personalized cell therapies.

Which Companies Form The Competitive Landscape Of The Stem Cell Therapy For Infertility Market?

Major companies operating in the stem cell therapy for infertility market are PlacidWay LLC, New Life India Fertility Clinic Private Limited, Jeevan Mithra Fertility Centre Private Limited, Equipo IVI S.L., Hope Fertility & Stem Cell Centre Pvt. Ltd., Bioscience Institute SpA, Advancells Dermaceuticals Private Limited, GIOSTAR INDIA PRIVATE LIMITED, Shree IVF Clinic Private Limited, Stem Cells Care (india) Private Limited, GenCell Ltd., StemRx BioScience Solutions Private Limited., Kiran Infertility Centre Private Limited, R3 Stem Cell LLC., Bavishi Fertility Institute Private Limited, Seragen Biotherapeutics Private Limited, Esha IVF Fertility Centre Private Limited, Embryonic Tissue Center EmCell, InoCells B.V., Vega Stem Cell Clinic Co. Ltd.

Access The Complete Stem Cell Therapy For Infertility Market Report:

https://www.thebusinessresearchcompany.com/report/global-stem-cell-therapy-for-infertility-market-report

Which Area Represents The Largest Portion Of The Stem Cell Therapy For Infertility Market?

North America was the largest region in the stem cell therapy for infertility market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the stem cell therapy for infertility market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Stem Cell Therapy For Infertility Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=30408&type=smp

Browse Through More Reports Similar to the Global Stem Cell Therapy For Infertility Market 2026, By The Business Research Company

Stem Cells Therapy Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

Fertility Drugs Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/fertility-drugs-global-market-report

Fertility Treatments Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/fertility-treatments-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Does The Market Size Of The Stem Cell Therapy For Infertility Market Compare Between 2026 And 2030?

The stem cell therapy for infertility market size has seen rapid expansion in recent years. It is anticipated to increase from $1.87 billion in 2025 to $2.18 billion in 2026, at a compound annual growth rate (CAGR) of 16.6%. This historical growth can be attributed to the rising prevalence of infertility conditions, the global expansion of fertility clinics, advancements in reproductive biology research, growing demand for alternative infertility treatments, and the increased adoption of assisted reproductive procedures.

The stem cell therapy for infertility market is projected to experience substantial expansion in the coming years. This market is anticipated to reach $3.99 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 16.4%. Factors contributing to this growth over the forecast period include enhanced clinical validation of stem cell treatments for infertility, greater investments in reproductive regenerative medicine, a growing embrace of personalized fertility approaches, an increase in clinical trials focused on reproductive health, and stronger partnerships between fertility clinics and research organizations. Key trends expected during the forecast period encompass a heightened emphasis on therapies for ovarian and testicular regeneration, a rise in the application of autologous stem cell treatments, increasing incorporation with assisted reproductive technologies, the broadening of personalized fertility treatment protocols, and intensified clinical research within reproductive regeneration.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30408&type=smp

What Significant Factors Are Influencing The Stem Cell Therapy For Infertility Market Expansion?

The escalating instances of infertility are projected to notably contribute to the expansion of the stem cell therapy for infertility market moving forward. Infertility is characterized as a couple’s inability to conceive after 12 months or more of regular unprotected sexual intercourse. The rising occurrence of infertility is largely ascribed to delayed childbearing, as many individuals opt to have children later in life, resulting in diminished fertility due to the natural decline in reproductive potential with age, particularly among women. Stem cell therapy for infertility offers promising remedies by regenerating impaired reproductive tissues, enhancing ovarian and testicular function, and boosting the likelihood of conception. For instance, in April 2023, a report from the World Health Organization (WHO), a Switzerland-based intergovernmental organization, revealed that infertility impacts approximately 17.5% of the adult population, or about 1 in 6 people globally, emphasizing the growing necessity to broaden access to affordable and high-quality fertility care. Hence, the increasing cases of infertility are expected to fuel the growth of the stem cell therapy for infertility market.

How Are Segments Identified Within The Stem Cell Therapy For Infertility Market Segment Framework?

The stem cell therapy for infertility market covered in this report is segmented –

1) By Type: Male Infertility Treatment, Female Infertility Treatment

2) By Treatment Type: Autologous Stem Cell Therapy, Allogeneic Stem Cell Therapy, Combination Therapy

3) By Cell Source: Embryonic Stem Cells, Adult Stem Cells, Induced Pluripotent Stem Cells

4) By Application: Ovarian Insufficiency, Uterine Infertility, Genetic Disorders

5) By End User: Hospitals, Specialty Clinics, Research Institutes

Subsegments:

1) By Male Infertility Treatment: Surgical Sperm Retrieval, Hormonal Therapy, Stem Cell Transplantation, Assisted Reproductive Techniques

2) By Female Infertility Treatment: Ovarian Stem Cell Therapy, Endometrial Regeneration Therapy, Hormonal Therapy, In Vitro Fertilization Enhancement

What Trends Are Affecting The Direction Of The Stem Cell Therapy For Infertility Market?

Major companies operating in the stem cell therapy for infertility market are concentrating on innovations in stem cell technologies, including induced pluripotent stem cells (iPSCs), with the aim of advancing personalized regenerative treatments, improving patient-specific results, and broadening the spectrum of treatable reproductive conditions. Induced pluripotent stem cells are adult somatic cells that have been genetically altered to achieve an embryonic-like pluripotent state, enabling their differentiation into virtually any cell type within the body. As an example, in January 2025, Gameto Inc., a US-based biotechnology company, commenced a pivotal Phase III clinical trial for its iPSC-derived fertility therapy, Fertilo, following Investigational New Drug (IND) approval from the U.S. Food and Drug Administration (FDA). This trial, which is being conducted at approximately 15 sites across the U.S., intends to evaluate egg maturation outside the body using engineered ovarian support cells, which could potentially shorten IVF cycles and decrease hormonal stimulation by up to 80%. If successful, this initiative will represent the first late-stage clinical program for an in-vitro matured egg therapy derived from induced pluripotent stem cells in the treatment of infertility.

Who Are The Companies Competing Within The Stem Cell Therapy For Infertility Market?

Major companies operating in the stem cell therapy for infertility market are PlacidWay LLC, New Life India Fertility Clinic Private Limited, Jeevan Mithra Fertility Centre Private Limited, Equipo IVI S.L., Hope Fertility & Stem Cell Centre Pvt. Ltd., Bioscience Institute SpA, Advancells Dermaceuticals Private Limited, GIOSTAR INDIA PRIVATE LIMITED, Shree IVF Clinic Private Limited, Stem Cells Care (india) Private Limited, GenCell Ltd., StemRx BioScience Solutions Private Limited., Kiran Infertility Centre Private Limited, R3 Stem Cell LLC., Bavishi Fertility Institute Private Limited, Seragen Biotherapeutics Private Limited, Esha IVF Fertility Centre Private Limited, Embryonic Tissue Center EmCell, InoCells B.V., Vega Stem Cell Clinic Co. Ltd.

Get The Full Stem Cell Therapy For Infertility Market Report:

https://www.thebusinessresearchcompany.com/report/global-stem-cell-therapy-for-infertility-market-report

Which Region Accounts For The Largest Portion Of The Stem Cell Therapy For Infertility Market?

North America was the largest region in the stem cell therapy for infertility market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the stem cell therapy for infertility market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Stem Cell Therapy For Infertility Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/global-stem-cell-therapy-for-infertility-market-report

Browse Through More Reports Similar to the Global Stem Cell Therapy For Infertility Market 2026, By The Business Research Company

Stem Cells Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

Fertility Drugs Market Report

https://www.thebusinessresearchcompany.com/report/fertility-drugs-global-market-report

Fertility Treatments Market Report

https://www.thebusinessresearchcompany.com/report/fertility-treatments-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Stem Cell Therapy For Infertility Market At The End Of The 2026–2030 Forecast Period?

The stem cell therapy for infertility market size has experienced rapid growth in recent years. It is projected to expand from $1.87 billion in 2025 to $2.18 billion in 2026, achieving a compound annual growth rate (CAGR) of 16.6%. Historically, this growth has been influenced by the increasing prevalence of infertility conditions, the global expansion of fertility clinics, advancements in reproductive biology research, a rising demand for alternative infertility treatments, and the broader application of assisted reproductive procedures.

The stem cell therapy for infertility market is anticipated to experience significant expansion over the coming years. Projections indicate it will reach $3.99 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 16.4%. This projected growth is driven by several factors, including the increasing clinical validation of stem cell treatments for infertility, a rise in investments dedicated to reproductive regenerative medicine, broader acceptance of personalized fertility solutions, the expansion of clinical trials in reproductive health, and enhanced collaboration between fertility clinics and research institutions. Key trends anticipated during this period encompass a heightened focus on therapies for ovarian and testicular regeneration, a rise in the application of autologous stem cell treatments, growing integration with assisted reproductive technologies, the expansion of personalized fertility treatment protocols, and intensified clinical research within reproductive regeneration.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30408&type=smp

What Primary Drivers Are Shaping The Development Of The Stem Cell Therapy For Infertility Market?

The increasing instances of infertility are anticipated to significantly contribute to the future expansion of the stem cell therapy for infertility market. Infertility is defined as a couple’s inability to achieve pregnancy following 12 months or longer of consistent unprotected sexual activity. This growing incidence of infertility is primarily linked to delayed parenthood, as a significant number of people opt to start families later, leading to a decrease in fertility stemming from the natural age-related reduction in reproductive capability, especially for women. Stem cell therapy for infertility presents encouraging solutions through the regeneration of impaired reproductive tissues, enhancement of ovarian and testicular functionality, and an improved likelihood of conception. As an illustration, a report released by the World Health Organization (WHO), a Switzerland-based intergovernmental body, in April 2023, indicated that roughly 17.5% of adults worldwide, or about 1 in 6 individuals, are impacted by infertility, underscoring the increasing demand for broader access to economical and high-standard fertility treatment. Consequently, the increasing prevalence of infertility is expected to propel the growth of the stem cell therapy for infertility market.

What Segment Types Make Up The Stem Cell Therapy For Infertility Market?

The stem cell therapy for infertility market covered in this report is segmented –

1) By Type: Male Infertility Treatment, Female Infertility Treatment

2) By Treatment Type: Autologous Stem Cell Therapy, Allogeneic Stem Cell Therapy, Combination Therapy

3) By Cell Source: Embryonic Stem Cells, Adult Stem Cells, Induced Pluripotent Stem Cells

4) By Application: Ovarian Insufficiency, Uterine Infertility, Genetic Disorders

5) By End User: Hospitals, Specialty Clinics, Research Institutes

Subsegments:

1) By Male Infertility Treatment: Surgical Sperm Retrieval, Hormonal Therapy, Stem Cell Transplantation, Assisted Reproductive Techniques

2) By Female Infertility Treatment: Ovarian Stem Cell Therapy, Endometrial Regeneration Therapy, Hormonal Therapy, In Vitro Fertilization Enhancement

How Are Trends Transforming The Stem Cell Therapy For Infertility Market Landscape?

Leading companies in the stem cell therapy for infertility market are concentrating on advancements in stem cell technologies, particularly induced pluripotent stem cells (iPSCs), with the goal of enhancing personalized regenerative treatments, improving patient outcomes, and expanding the spectrum of treatable reproductive conditions. Induced pluripotent stem cells are adult somatic cells that have been genetically reprogrammed to achieve an embryonic-like pluripotent state, enabling them to differentiate into almost any cell type within the body. For instance, in January 2025, Gameto Inc., a US-based biotechnology company, commenced a pivotal Phase III clinical trial for its iPSC-derived fertility therapy, Fertilo, following the Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA). This trial, involving approximately 15 sites across the U.S., seeks to evaluate egg maturation outside the body utilizing engineered ovarian support cells, potentially shortening IVF cycles and reducing hormonal stimulation by up to 80%. If proven successful, this would constitute the inaugural late-stage clinical program for an in-vitro matured egg therapy, derived from induced pluripotent stem cells, aimed at treating infertility.

Who Are The Key Players Driving Competition In The Stem Cell Therapy For Infertility Market?

Major companies operating in the stem cell therapy for infertility market are PlacidWay LLC, New Life India Fertility Clinic Private Limited, Jeevan Mithra Fertility Centre Private Limited, Equipo IVI S.L., Hope Fertility & Stem Cell Centre Pvt. Ltd., Bioscience Institute SpA, Advancells Dermaceuticals Private Limited, GIOSTAR INDIA PRIVATE LIMITED, Shree IVF Clinic Private Limited, Stem Cells Care (india) Private Limited, GenCell Ltd., StemRx BioScience Solutions Private Limited., Kiran Infertility Centre Private Limited, R3 Stem Cell LLC., Bavishi Fertility Institute Private Limited, Seragen Biotherapeutics Private Limited, Esha IVF Fertility Centre Private Limited, Embryonic Tissue Center EmCell, InoCells B.V., Vega Stem Cell Clinic Co. Ltd.

Read the full stem cell therapy for infertility market report here:

https://www.thebusinessresearchcompany.com/report/global-stem-cell-therapy-for-infertility-market-report

How Does The Stem Cell Therapy For Infertility Market Perform Across Major Global Regions?

North America was the largest region in the stem cell therapy for infertility market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the stem cell therapy for infertility market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Stem Cell Therapy For Infertility Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=30408&type=smp

Browse Through More Reports Similar to the Global Stem Cell Therapy For Infertility Market 2026, By The Business Research Company

Stem Cells Therapy Global Market Report

https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

Fertility Drugs Global Market Report

https://www.thebusinessresearchcompany.com/report/fertility-drugs-global-market-report

Fertility Treatments Global Market Report

https://www.thebusinessresearchcompany.com/report/fertility-treatments-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model